Introduction
which showed that incubation of human myometrial cells in culture with HCG for 4-8 h directly Elucidation of the myometrial mechanisms that regulate uterine decreases expression of connexin-43 gap junction mRNA and activity during human pregnancy remains a high priority in protein concentrations via activation of protein kinase A the search for better therapeutic agents to control the incidence (PKA). Connexin-43 plays an important part in vivo in regulatof premature labour. Although a great deal of effort has ing uterine contractions during labour and its expression recently been focused on the study of nitric oxide synthase increases in the myometrium prior to the onset of parturition (NOS) in the maintenance of uterine quiescence during preg- (Chow and Lye, 1994) , and this may be related to the reciprocal nancy, there is at present only controversial evidence to support decrease in concentrations of expression of HCG receptors a role for nitric oxide (NO) as a major relaxatory agent of and Gαs. Moreover, observations by Yang et al. (1997) indicate human uterine smooth muscle cells (Weiner et al., 1994;  that over-expression of Gαs in transfected cells increases events Kuenzli et al., 1996; Nakanishi et al., 1996; Jones and Poston, distal to cAMP accumulation, resulting in phosphorylation 1997; Sladek et al., 1997; Thomson et al., 1997; Hennan and of cAMP-dependent transcription factors by PKA and the Diamond, 1998). However, the role of cyclic AMP (cAMP) subsequent activation of gene expression in these cells. The in the regulation of myometrial quiescence is supported by most studied cAMP-dependent transcription factors include several studies indicating that increased formation of cAMP the cAMP response-element binding protein (CREB; Hoeffler during pregnancy is potentiated by up-regulation of isoforms et al., 1988) and modulator protein (CREM; Foulkes et al., of the GTP-binding protein (G-protein) Gαs (Europe-Finner 1991) , and members of the activating transcription factor et , 1994 Lopez Bernal et al., 1995) ; this is coupled to (ATF) sub-family. These factors bind to specific regulatory increased human chorionic gonadotrophin (HCG/LH) receptor sequences in the promoters of the genes that they control (Lalli expression/HCG concentrations (Zuo et al., 1994) and the and , and are all members of the basic progesterone-induced decrease in cAMP phosphodiesterase region/leucine zipper (bZIP) superfamily of proteins activity observed during pregnancy (Kofinas et al., 1990) . (Landschulz et al., 1988; Ziff, 1990) . The best characterized Increased cAMP accumulation during gestation may potentially of these binding motifs is the cAMP-response element (CRE), affect the expression of other key genes involved in regulating a consensus palindromic sequence in the form 5Ј-TGACGTCAthe activity of the human uterus throughout fetal maturation and labour. This hypothesis is supported by previous findings 3Ј to which proteins from the CREB/CREM/ATF family of and obtained from Bio-Rad (Richmond, CA, USA). Antibodies to transcription factors bind as homo-or heterodimers (Sassone-CREB (06-504) and phosphoCREB (06-519) were obtained from Corsi, 1988; Borrelli et al., 1992) . Both CREB and CREM Upstate Biotechnology (Lake Placid, NY, USA). Antibodies to are derived from multi-exonic genes, the alternative splicing CREB-1 (CREB-specific, directed towards an epitope corresponding of which generates a complex array of isoproteins that can act to amino-acids 254-327; X-12), CREM-1 (CREB/CREM/ATF as both activators and repressors of transcription (Sun et al., specific; X-12), 1992; Walker et al., 1994; Habener et al., 1995; Sanborn et al., c-Fos, c-Jun and full length CREM protein were obtained from Santa 1997). While ATF2 and ATF3 are products of distinct genes
Cruz Biotechnology (Santa Cruz, CA, USA). Similarly electrophoretic (Maekawa et al., 1989; Gaire et al., 1990; Kara et al., 1990;  mobility super shift antibodies to CREB-1, CREM-1 and ATF1-4 Adam et al., 1996; Liang et al., 1996) , ATF1 is known to be were also obtained from Santa Cruz Biotechnology. The Gβ antibody highly homologous to CREB lacking a glutanide rich region (SW/1) was from NEN (USA). Horseradish peroxidase conjugated goat anti-rabbit immunoglobulin G (IgG)/goat anti-mouse IgG were just upstream of the phosphorylation regulatory domain (P- receptor (OTR), cyclo-oxygenase 2 (COX-2) and connexin-43
Pregnant non-labouring and spontaneous labouring genes. Moreover, previous studies Moonen myometrium et al., 1986; Sparey et al., 1999) 
Materials and methods

Preparation of myometrial homogenates and cell lysates Reagents
for Western blotting/mobility shift assays All electrophoretic reagents, including low molecular weight preAll procedures were carried out on ice. (i) Tissue samples were homogenized at a ratio of 1:10 in 25 mmol/l Tris buffer, pH 7.6, stained and unstained standards, were of the highest grade available containing 0.25 mol/l sucrose and 1 mmol/l EDTA in the presence X-100 (all from Sigma), overnight at 4°C. This was pre-cleared to of pepstatin, leupeptin, aprotinin and phenylmethylsulphonyl fluoide minimize non-specific reactions with the precipitating primary serum (PMSF) protease inhibitors. Homogenates were then centrifuged at by incubation with 5 µg of normal IgG from the same species as the 1000 g to remove tissue debris, the genomic DNA sheared by antibody and 20 µl of protein A agarose suspension with agitation at centrifugation through QIAshredder columns (QIAgen, Crawley, UK) 4°C for 30 min. The agarose was pelleted by microcentrifugation at and the supernatants stored at -70°C. (ii) Primary myometrial cell 3000 rpm (700 g) for 5 min, and the supernatant was transferred to cultures were prepared from non-pregnant/pregnant non-labouring a fresh tube. 10 µg of the precipitating primary antibody was added myometrial biopsies as described previously per mg of total protein, and incubated at 4°C for 1 h with agitation. and used prior to passage three. Whole cell lysates were prepared by 15 µl of the protein A agarose suspension was then added, and resuspending harvested and washed cells in 150 µl buffer 1 per incubation continued as above overnight. The sample was centrifuged confluent T75 flask [10 mmol/l HEPES (pH 7.9), 10 mmol/l KCl, as above, and the pellet washed with 1 ml of cold PBS, followed by 1.5 mmol/l MgCl 2 , 0.5 mmol/l dithiothreitol (DTT), 1 mmol/l sodium another centrifugation step. This was repeated four times, after which orthovanadate, 1 mmol/l NaF, 1% NP-40, plus protease inhibitors as the precipitated protein was eluted from the agarose by incubating above]. The samples were vortexed, incubated on ice for 10 min, and with an equal volume of 2ϫ Laemmli buffer at 80°C for 5 min. The micro-centrifuged at 7000 rpm (3000 g) for 1 min. Pellets were sample was microcentrifuged at 13 000 rpm (12 000 g) for 5 min to resuspended in 30 µl of buffer 2 per original T75 flask [20 mmol/l pellet the agarose, and the eluted protein subjected to SDS-PAGE HEPES (pH 7.9), 0.42 mol/l NaCl, 1.2 mmol/l MgCl 2 , 0.5 mmol/l and Western blotting analysis as above. DTT, 0.3 mmol/l EDTA, 25% glycerol, plus protease inhibitors as above]. After incubation on ice for 1 h with occasional vortexing, Two-dimensional SDS-PAGE the samples were micro-centrifuged at 13 000 rpm (12 000 g) for 30
Immunoprecipitated proteins were subjected to 2-D SDS-PAGE using min at 4°C, and the supernatants stored at -70°C.
the BioRad Mini-PROTEAN II 2-D cell and tube module, according When the homogenates/lysates were to be used in EMSAs, they to the published protocol. Briefly, 0.5 mg of total protein from cleared were dialysed prior to storage against a 1000ϫ volume of 20 mmol/ myometrial homogenate was precipitated using 0.5 µg of primary l HEPES (pH 7.9), 5 mmol/l MgCl 2 , 1 mmol/l EDTA, 70 mmol/l antibody and 50 µl of protein A agarose as above, and eluted in 50 KCl, 5 mmol/l DTT, 10% glycerol at 4°C overnight. In all cases, the µl of 1st dimension sample buffer (9.5 mol/l urea, 2% de-ionized total protein content of each sample was assayed using the DC protein Triton X-100, 5% β-mercaptoethanol, 1.6% 5/7 ampholyte and 0.4% assay kit (BioRad) with bovine serum albumin (BSA) as standard.
3/10 ampholyte). Following pre-electrophoresis of the 1st dimension tube gels using 100 mmol/l NaOH and 10 mmol/l H 3 PO 4 as the Western blot immunodetection of myometrial proteins upper and lower chamber buffers respectively, 5 µl of this was loaded Total protein (500 µg) from each myometrial homogenate was onto the surface of the tube gels, overlayed with 20 µl of sample solubilized in sample buffer and resolved on 12.5% polyacrylamide overlay buffer (9 mol/l urea, 0.8% 5/7 ampholyte, 0.2% 3/10 gels containing 0.0625% bis-acrylamide for 4 h at 50 mA and then ampholyte, Bromophenol Blue; diluted 5ϫ prior to use), and elecelecrotransferred onto a polyvinylidine difluoride (PVDF) membrane trophoresed at 750 V for 3.5 h. The gels were then extracted from (Hybond-P; Amersham) at 90 V for 2 h using a Trans-Blot cell their capillary tubes, and layered onto the surface of mini slab gels (BioRad). These membranes were subjected to a blocking step for 1 for the 2nd dimension run. The electrophoresed proteins were then h at room temperature in 5% non-fat milk. Primary antibodies to blotted onto PVDF membranes for immunodetection, as above. CREB and phospho-CREB were used at 4 µg/ml, and to CREM (anti-CREM-1) and ATF1-4 at 0.15 µg/ml, all in the presence of 5% Electrophoretic mobility shift and super shift assays non-fat milk and 0.05% Tween 20 in 1ϫ phosphate buffered saline Sense and antisense oligonucleotides corresponding to the CREs of (PBS) overnight at 4°C. The primary antiserum was then removed, the HCG (5Ј-ATGGTAAAAATTGACGTCATGGTAATTACA-3Ј), and blots washed thoroughly with PBS. Blots were then incubated with human β2 adrenoceptor (hβ2-AR; 5Ј-CGAAAGTTCCCGTACGTCgoat anti-rabbit IgG or goat anti-mouse IgG coupled to horseradish ACGGCGAGGGCA-3Ј), rat somatostatin (rat-SS; 5Ј-AGAGATTGCperoxidase at a 1:2000 dilution in PBS for l h at room temperature, CTGACGTCAGAGAGCTAG-3Ј), COX-2 (5Ј-CCTATTAAGCthen rinsed thoroughly with PBS as before. Antibody complexes were GTCGTCACTAAAACATA-3Ј), connexin-43 (Cx-43; 5Ј-CAAGTAdetected by ECL using X-O-Mat X-ray film. Data were obtained GAGGCGTTCATGTCCCTAAT-3Ј) and OTR (5Ј-GGAGCGCACGunder conditions where a linear relationship existed between the CGTCACTGGGGCCGT-3Ј) genes were end-labelled with [γ 32 P]-amount of protein loaded and the intensity of the ECL signal from the immunoblots.
ATP, annealed and purified using ProbeQuant G-50 microcolumns In all cases, the loading of equivalent amounts of total protein for (Amersham-Pharmacia Biotech); OCT-1 sequence-containing oligoeach sample was confirmed by Ponceau S staining of the PVDF nucleotides for use as a negative control (OCT-1 5Ј-TTCTAGTGATTmembrane after electroblotting and subsequent densitometric scan-TGCATTCGACA-3Ј) were treated similarly. Approximately 40 000 ning. For blots involving myometrial tissue from the upper and lower cpm of these substrates were then used in each binding reaction, in uterine segments, where the latter may contain a higher amount of a total volume of 15 µl with 1 µg of poly (dI-dC) (Pharmacia), 30 µg connective tissue, equivalent smooth-muscle protein loading was also of total cellular protein, 25 mmol/l HEPES (pH 7.5), 10% glycerol, confirmed by immunodetection with an antibody common to all Gβ 5 mmol/l MgCl 2 , 100 mmol/l KCl, 1 mmol/l DTT, 0.2 mmol/l EDTA, subunits, which are known to be expressed to similar values in the 0.5 mg/ml BSA, and 200-fold cold competitor oligonucleotide where myometrial cells of the non-pregnant, pregnant non-labouring and applicable in competition experiments. Competitors were added to spontaneous labouring uterus (Europe-Finner et al., 1994;  Hattachote the reactions 15 min prior to the addition of the probe, after which et Sparey et al., 1999) .
they were incubated for a further 15 min at room temperature. In the case of the super shift experiments, 2 µl of the appropriate antibody Immunoprecipitation of proteins was incubated with the protein extract for 30 min at room temperature before the addition of the probe, and the reactions were continued as Cleared myometrial homogenate was dialysed against a 1000ϫ volume of 1ϫ PBS, 0.5% deoxycholic acid, 0.1% SDS, 0.1% Triton above. The samples were then subjected to 4% non-denaturing PAGE at 150 V for 3 h, after which time the gels were dried and exposed to X-ray film.
Results
Immunodetection and expression of myometrial CREB, CREM and ATF1-4 proteins
Immunoblotting of total protein extracts from non-pregnant, pregnant non-labouring and spontaneous labouring myometrial tissues sampled from the lower uterine segment with an anti-CREM-1 (CREB/CREM/ATF1 and ATF4) antibody showed a significant difference in the isoforms of these proteins expressed in the three types of tissue ( Figure 1a) . A protein of apparent molecular mass 43 kDa was prevalent almost exclusively in non-pregnant (NP) myometrium (Figure 1b) , whereas a protein of~28 kDa was detected primarily in pregnant non-labouring myometrium (P) which was subsequently expressed at much higher concentrations in spontaneous labouring (SL) tissues ( Figure 1c ). In all three tissue types, a 39 kDa protein was detected, the expression of which was significantly decreased in P and SL tissues, compared with NP myometrium (Figure 1d ). The 43 and 39 kDa proteins reported here have similar apparent molecular weights to those reported previously (Habener et al., 1995; Müller et al., 1997) for CREB/CREM/ATF transcription factors. Furthermore, immunoblotting of a HeLa cell extract as a standard control (for identification of nuclear factors) also confirmed the identity of the proteins detected in the myometrial homogenates as CREB/CREM/ATF proteins. , pregnant nonlabouring (P) and spontaneous labouring (SL) women. Proteins were resolved from homogenized tissue samples by 12.5% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) of 500 µg of total protein for each sample, electroblotting onto a polyvinylidine difluoride (PVDF) membrane, and detection using the primary anti-CREM-1 antibody at 0.15 µg/ml, secondary horseradish peroxidase (HRP)-conjugated goat anti-rabbit immunoglobulin G (IgG) at a 1/2000 dilution, and the enhanced chemiluminescence (ECL) assay system. A HeLa cell extract was used as a positive control. Three species of proteins were found as indicated in the representative blot of apparent molecular weights 43, 39 and 28 kDa. Analysis of this, and further blots, by scanning densitometry revealed patterns of expression of these proteins summarized in Figure 1b Immunodetection of full-length CREM protein in lower uterine myometrial samples from non-pregnant (NP), pregnant nonlabouring (P) and spontaneous labouring (SL) women in addition to purified full-length CREM and rat kidney-cell (RKL) lysate controls is shown. Electroblotted proteins were subjected to immunodetection using the primary anti-CREM-1 antibody at 0.15 µg/ml, secondary horseradish peroxidase (HRP)-conjugated goat anti-rabbit immunoglobulin G (IgG) at a 1/2000 dilution, and the Figure 2 . Immunodetection of (a) cAMP response-element binding enhanced chemiluminescence (ECL) assay system. Lane 1 ϭ protein (CREB) and (b) phospho-CREB proteins in lower uterine CREM-1 full-length protein control; lane 2 ϭ rat kidney-cell lysate myometrial samples from non-pregnant (NP), pregnant noncontrol; lanes 3-5 ϭ 500 µg of total myometrial proteins from nonlabouring (P) and spontaneous labouring (SL) women.
pregnant (NP), pregnant (P) and spontaneous labouring (SL) tissue Electroblotted proteins were detected using the primary anti-CREB (n ϭ 1) respectively. Full-length CREM-1 protein was detected in (a) and anti-phospho-CREB (b) antibodies at 4 µg/ml, secondary the control (lanes 1 and 2), with a mobility identical to that of the horseradish peroxidase ( 1. It was therefore concluded that the 39 kDa protein detected in the myometrial homogenates was the full-length CREM protein, whilst the 28 kDa protein that was not detected in the Due to the cross-reactivity of the anti-CREM-1 (CREB/ CREM/ATF) antibody with the CREB, CREM and ATF rat kidney lysate (lane 2) might be a derivative of CREM, one of the ATF proteins, or a novel protein which appears to be proteins (Santa Cruz product information), immunoblots were repeated using a specific anti-CREB antibody directed towards related to the bZIP family of transcription factors. In light of the following results we have termed this protein CREM-28. epitopes in the highly variable 200 amino-terminal residues of the protein; this antibody is designed to specifically recognize Identical immunoblotting experiments were also performed using primary antibodies to the ATF proteins 1-4. Although inactive and active forms of CREB but not CREM or ATF (Ginty et al., 1993; Baler et al., 1997) . Figure 2a shows the 500 µg of tissue homogenate protein was loaded per lane, ATF1, ATF3 and ATF4 proteins remained undetected using detection of the 43 kDa full-length protein primarily in nonpregnant tissues, with much reduced concentrations in pregnant antibodies specific to these proteins. In contrast, bands corresponding to proteins of approximate molecular mass 60 kDa and labouring tissue samples. This identifies this protein as an isoform of CREB; parallel blots using an anti-phospho-CREB and 28 kDa were identified using the antibody to ATF2 ( Figure  4a ). The 60 kDa protein, ostensibly the full-length 60-68 kDa antibody (directed towards an epitope comprising the phosphorylated Ser 133 residue of full-length CREB and consequently ATF2 protein (Maekawa et al., 1989; Gaire et al., 1990; Kara et al., 1990; Adam et al., 1996; Liang et al., 1996) , was recognising activated CREB/CREM/ATF proteins) suggest that the full-length 43 kDa CREB protein detected mainly in nonfound to be expressed mainly in non-pregnant myometrium at concentrations significantly higher than in pregnant nonpregnant tissue is in its phosphorylated and active form ( Figure  2b ), although this result is not definitive due to the documented labouring and spontaneous labouring tissues (Figure 4b ). The 28 kDa protein (hereafter referred to as ATF2-28) was cross-reactivity of this antibody with other closely related proteins.
expressed in all tissue types, with concentrations of this protein decreasing significantly from the non-pregnant to the pregnant The specific recognition of only the 43 kDa protein species by the anti-CREB antibody identified the 39 kDa and 28 kDa non-labouring/spontaneous labouring state (Figure 4c ). In control experiments all antibodies were substituted with nonproteins detected in Figure 1 as CREM/ATF transcription factors; these were further investigated by blotting appropriate immune sera from animals in which the antibodies were raised (data not shown). In all cases immunodetected bands were protein samples from non-pregnant, pregnant and spontaneous labouring myometrial samples alongside purified full-length found to be specific. The specific expression of CREB, CREM and ATF2 proteins in uterine smooth-muscle cells was also samples obtained from individual women (Sparey et al., 1999) . In all cases, the loading of equivalent amounts of total protein confirmed by immunohistochemical staining of paraffinembedded myometrial sections prepared from the three tissue for each sample was confirmed by staining of the blotted membranes with Ponceau S solution (Sigma, UK) and scanning types (data not shown).
prior to immunodetection, and by re-probing the blots with an Expression of myometrial CREM (28 kDa) and ATF2-anti-Gβ antibody. The Gβ protein subunits have consistently like (28 kDa) proteins in the upper and lower uterine been shown to be expressed to similar levels in the upper segments during pregnancy and labour and lower uterine segment myometrium from pregnant nonlabouring and spontaneous labouring patients (Sparey et al., From Western blot analysis the two main cAMP-dependent transcription factors that are expressed in the human myome-1999), and this is confirmed in Figure 5b ,e. Immunoblotting of homogenized upper and lower myometrial samples using the trium during gestation and parturition appear to be the CREM 28 kDa and ATF2-like 28 kDa proteins. Consequently, further anti-CREM-1 (CREB/CREM/ATF) and anti-ATF2 antibodies revealed that while myometrial CREM-28 was expressed to immunodetection experiments were performed to monitor the spatial expression of these proteins in myometrial tissues taken similar values in the upper and lower uterine regions during pregnancy and at increased concentrations in both uterine from the upper (corpus) and lower uterine regions using paired regions during labour as described previously, there was a consistent and striking difference between concentrations of expression of myometrial ATF2-28 in upper and lower uterine samples (Figure 5a ,c,d). In this respect, a comparison of the optical density (OD) values that are a measure of the levels of expression of this protein indicated a decreased level of myometrial expression in the lower uterine segment (0.5 OD units) compared with the upper (1.5-2.0 OD units) during pregnancy and labour.
Expression of the myometrial ATF2 28 kDa protein in the upper and lower regions of the non-pregnant uterus
While it seems clear that ATF2-28 is expressed differentially in different regions of the human myometrium throughout pregnancy and labour, the question arose as to whether this gradient of ATF2-28 concentrations from the corpus to the lower segment of the uterus was induced at some point following conception, or whether it also existed in the nonpregnant uterus. To address this, further anti-ATF2 immuno- blots were performed using samples of homogenized upper and lower myometrium from non-pregnant uteri. In all cases, results indicated the uniform expression of this protein in nonpregnant myometrial tissues (1.5-2.0 OD units; Figure 6a ,b). It is also worthy of note that the levels of expression of ATF2-28 in both the upper and lower non-pregnant uterine segments, as determined by OD values, were equivalent to the values observed for non-pregnant tissues in Figure 4c (where n ϭ 25), and for upper pregnant/labouring myometrial segments in Figure 5d , thus suggesting that ATF2-28 protein expression is down-regulated specifically in the lower pregnant/labouring myometrial segment compared with non-pregnant tissue.
Further characterization of the myometrial CREM-28 and ATF2-28 proteins
As detailed above, the potentially novel 28 kDa CREM and ATF2-like proteins appear to be the most prevalent proteins of this type in the pregnant non-labouring and spontaneous labouring myometrium. An important property of these types of protein is their ability to form homo-and heterodimers, an attribute that enables such complexes to exert alternate effects upon the genes that they regulate. To determine the extent of any interaction between the CREM-28 and ATF2-28 proteins, and also to provide further evidence for the ATF2-28 protein being a possible isoform derived from the ATF2 gene, the anti-CREM-1 (CREB/CREM/ATF) and anti-ATF2 antibodies were used in separate immunoprecipitation reactions with Figure 7 where immunoprecipitation with the anti-ATF2 antibody resulted in the weak cobetween these two proteins; Hoeffler et al., 1991) , these results provide further evidence of similarity between ATF2 and precipitation of CREM-28 protein as detected by the anti-CREM-1 antibody; note that only very small amounts of ATF2-28, and this may suggest a similar genetic basis. Due to the multiple-exonic structure of the genes and the CREB-43 and CREM-39 were precipitated in comparison to the high amounts of CREM-28. In parallel experiments the differential splicing of their primary transcripts (Foulkes et al., 1991; Ruppert et al., 1992; Laoide et al., 1993;  Meyer and anti-CREM-1 antibody was also able to co-immunoprecipitate a small amount of ATF2-28, and in each case the specificity Habener, 1993; Habener et al., 1995; Girardet et al., 1996; Walker et al., 1996; Gellersen et al., 1997) , CREM and ATF of the immunoprecipitation reactions was confirmed by the inclusion of appropriate negative control reactions (data not proteins are known to exist in several distinct isoforms. To determine the degree of homogeneity of the constituent proteins shown).
Further immunoprecipitation experiments were performed of the bands representing CREM-28 and ATF2-28 following normal SDS-PAGE, the immunoprecipitates, which predomito investigate whether the ATF-28 protein is a product of a splice-variant of the ATF2 gene. These were in the form of nantly contain CREM-28 and ATF2-28 respectively, were subjected to 2-D PAGE. This technique, involving the separaco-immunoprecipitations with antibodies to the related bZIP transcription factors c-Jun and c-Fos; ATF2 has previously tion of proteins according to their iso-electric points prior to separation in terms of size via conventional slab-gel electrobeen shown by co-immunoprecipitation and Western blotting to interact with the former but not the latter (Maekawa et al., phoresis, produced the results shown in Figure 9 after subsequent electroblotting and immunodetection. Figure 9a  1989 ; Benbrook and Jones, 1990; Ivashkiv et al., 1990 ; (CREM-28) and 28 kDa form of activating transcription factor 2 suggesting a positive interaction and formation of heterodimers protein (ATF2-2). 50 µg of precipitated protein using the antibetween these proteins.
CREM-1 (CREB/CREM) and anti-ATF2 antibodies from pooled P/ SL myometrial homogenate was subjected to iso-electric focusing followed by SDS-PAGE according to the protocol detailed in indicates the presence of three proteins specifically precipitated using the anti-ATF2 antibody, which identified the presence of six differentially-focussed proteins, each with a molecular weight of 28 kDa. Figure 10b , lane 3). Super shifts were also detected with antibodies specific for CREB, CREM and ATF 1-4 transcripElectrophoretic mobility shift assays tion factors (Figure 10a , lanes 7-12; Fig 10b, lanes 4-6) , note that incubation with the ATF3 antibody causes a marked Electrophoretic mobility shifts were observed with wholecell lysates of cultured human myometrial cells and several reduction in the amount of the labelled band shift obtained, compared with the other antibodies used, indicating a CREsymmetrical (5Ј-TGACGTCA-3Ј) and asymmetrical (5Ј-CGTCA-3Ј) CRE-containing 32 P-labelled oligonucleotides.
specific DNA-binding activity of these proteins in human myometrial cells. No super shifts were observed in controls Figure 10a shows an example of a mobility shift obtained with the palindromic-CRE containing rat somatostatin (ratusing pre-immune serum in place of antibody (data not shown). In contrast to Western immunoblotting, ATF1, ATF3 and SS) oligonucleotide; similar shifts were also found with the palindromic HCG-CRE and hβ2AR-CRE oligonucleotides, ATF4 antibodies were capable of super shifting bands and consequently their detection may be due to the greater sensitivbut not with the negative control non CRE-containing OCT-1 oligonucleotide (data not shown). Band shifts were also ity of the EMSA. Similar shift and super shifts were also obtained using whole tissue extracts from a pool of pregnant observed using the asymmetrical OTR-CRE (Figure 10b) , as well as COX2-CRE (data not shown). For both symmetrical non-labouring/spontaneous labouring myometrial samples containing two or three individual samples from each patient and asymmetrical CRE [ 32 P]-labelled olignucleotides the observed shifts were efficiently competed away with a 200-group. Figure 10c shows a typical EMSA using the [ 32 P]-labelled CRE containing rat-SS oligonucleotide with the super fold excess of non-labelled CRE-containing oligonucleotides (Figure 10a, lanes 3 and 4; Figure 10b , lane 2), but not with shift antibodies detailed previously; note that two super shift complexes were observed, complex I having a high intensity the non-CRE containing OCT-1 sequence ( Figure 10a , lane 5; whereas complex II was of a lesser intensity (Figure 10c , lanes specific bands and no shifts or super shifts were observed (data not shown). 3-8). The existence of one extra and one higher intensity complex with tissue-derived proteins may be due to higher levels of expression and/or the occurrence of different homo-/ Discussion heterodimeric complexes, revealed by their interaction with the
The results presented here demonstrate the ability of CREB, super shift antibodies. When using either tissue or myometrial CREM and ATF1-4 proteins from both myometrial homogenwhole cell lysates in conjunction with the labelled asymmetrical ates and cultured cells to bind a variety of symmetrical CRE-containing connexin-43 oligonucleotide, only nonand asymmetrical CRE-containing DNA oligonucleotides, and more importantly reveal a significant switch in the isoforms of these proteins expressed in the human myometrium at the beginning or during the course of pregnancy. In summary; levels of CREB isoform of apparent molecular weight 43 kDa, the full-length and ubiquitously expressed 341 amino acid CREB-341 protein (Sun et al., 1992) , were found to be significantly lower in pregnant non-labouring tissue compared to non-pregnant tissue; this protein was detected only at very low concentrations in spontaneous labouring myometrium. A CREM protein with an apparent molecular weight of 39 kDa followed a similar pattern of expression, although concentrations were not found to decrease in the pregnant non-labouring and spontaneous labouring tissues quite so dramatically. A putative CREM-like protein of apparent molecular weight 28 kDa, completely absent in the non-pregnant myometrium, was expressed to a high level in pregnant non-labouring tissues and up-regulated even further in the spontaneous labouring samples. Expression of the closely related transcription factors ATF1, ATF3 and ATF4 was revealed only by EMSA experiments and was undetected in all tissues by Western blotting, but two apparent isoforms of ATF2 were identified; one protein of apparent molecular weight 60 kDa, ostensibly the fulllength ATF2 protein, was found to be expressed at a high level in the non-pregnant myometrium, at lower levels in pregnant non-labouring tissues, and at greatly decreased levels in spontaneous labouring samples. A previously unidentified protein of apparent molecular weight 28 kDa was also expressed at a high level in non-pregnant tissue, but appeared to be down-regulated to similar levels of expression in both the pregnant non-labouring and spontaneous labouring indicate specific DNA binding to the labelled connexin-43 oligonucleotide by the CREB, CREM or ATF1-4 proteins, it myometrium.
Further investigation revealed the differential expression of is known that the connexin-43 promoter contains multiple binding sites for the c-Jun/c-Fos group of bZIP transcription the ATF2-28 protein in the upper and lower regions of the uterus during pregnancy and labour. Comparison with the factors (AP1 binding sites). These bZIP proteins are known to form heterodimeric complexes (Benbrook and Jones, 1990 ; pattern of expression in non-pregnant tissues confirmed that the spatial change in concentrations of ATF2-28 occurred at Ivashkiv et al., 1990; Macgregor et al., 1990) with members of the CREB/CREM/ATF group of bZIP factors, therefore some point following conception, evidently brought about by the down-regulation of ATF2-28 in the lower segment of the the formation of such complexes may indirectly affect the expression of the myometrial connexin-43 gene as well as uterus. In contrast, expression of the prevalent CREM-28 protein remained at equivalent levels in the upper and lower other genes containing AP-1 and CRE elements (Angel and Karin, 1992; Geimonen et al., 1996) . Like ATF2-28, Sparey uterine segments during pregnancy but was substantially increased in both regions of the uterus during parturition. et al. (1999) found the gradient of connexin-43 protein expression to be from the corpus to the cervix, whereas the gradient Co-immunoprecipitation experiments demonstrated the weak ability of the CREM-28 and ATF2-28 proteins to form heterodiof expression of COX-1 and COX-2 was found to be the converse with the highest concentrations of both enzymes mers, whereas ATF2-60 and ATF2-28 were both shown to form strong heterodimer complexes with c-Jun as has been observed in the lower, compared with the upper, uterine segment. previously described (Maekawa et al., 1989) . Furthermore, 2-D PAGE analysis revealed the existence of six apparent forms These investigations are consistent with the idea that the differential expression of COX-1 and COX-2 and connexinof the ATF2-28 protein.
Although this present investigation may only define the 43 in the uterus may allow cervical ripening prior to and dilatation during labour and facilitate effective propagation of capability of the above cAMP-dependent transcription factors to bind DNA containing CRE sequences and not their funccontractions from corpus to cervix, as suggested by Sparey et al. (1999) . This pattern of myometrial gene expression in tionality in regulating specific myometrial genes, it is tempting to speculate about the possible roles of these proteins in the uterus prior to and during labour may well be aided in part by the differential expression of CREB, CREM and ATF2 modulating myometrial gene expression during pregnancy and the onset of labour at term. The switch between the expression transcription factors described here. Recently, it has been shown (Stevens et al., 1998) that the myometrial corticotrophinof the CREB-43 and CREM-28 proteins in the transition from the non-pregnant to the pregnant non-labouring state suggests releasing hormone receptor sub-type 1 (CRH-R1) is also differentially expressed within the human uterus during gestathat these proteins, both potent activators and/or repressors of the transcription of target genes containing CRE elements in tion and parturition with the highest levels expressed in the lower, compared with the upper, uterine segment. their promoters, may play an important role in the control of uterine activity throughout the 37-40 weeks of pregnancy. For
In summary, we present further evidence to support a role for cAMP in the control of uterine activity throughout weeks example, the substantial reduction during pregnancy in the concentration of the putative full-length CREB protein may 37-40 of pregnancy and labour. It appears that the CREM-28 and ATF2-28 proteins identified here may be important due to have far-reaching effects in terms of gene expression in human uterine smooth muscle cells; CREB is known not only to the differences in their spatial and temporal expression. It is therefore our immediate intention to clone and characterize activate the transcription of CRE-containing genes (Brindle and Montminy, 1992) , but also to be a potent inhibitor of these factors, and to further elucidate their roles in the control of uterine activity during pregnancy. the transcription of a diverse range of transcription factors (Lemaigre et al., 1993) .
Similarly, the increase in expression of the CREM-28 protein
